Product Images Bendamustine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Bendamustine NDC 71288-102 by Meitheal Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

structural formula - ben0e 0004 01

structural formula - ben0e 0004 01

Figure 1 - ben0e 0004 02

Figure 1 - ben0e 0004 02

PRINCIPAL DISPLAY PANEL – Bendamustine HCl for Injection, USP 25 mg Vial Label - ben0e 0004 03

PRINCIPAL DISPLAY PANEL – Bendamustine HCl for Injection, USP 25 mg Vial Label - ben0e 0004 03

PRINCIPAL DISPLAY PANEL – Bendamustine HCl for Injection, USP 25 mg Carton - ben0e 0004 04

PRINCIPAL DISPLAY PANEL – Bendamustine HCl for Injection, USP 25 mg Carton - ben0e 0004 04

This text appears to be a description of a drug called "Bendamustine HCI for Injection, USP" by Meitheal Pharmaceuticals. Each vial contains 25mg of the drug and 42.5mg of mannitol. It is recommended to be reconstituted with 5mL of Sterile Water for Injection, USP and should be used within 2-3 hours after reconstitution. The drug is for intravenous infusion only and is a cytotoxic agent used for cancer treatment. Detailed instructions for reconstitution and dilution are mentioned in the insert. The text also mentions precautions for handling and preparing the drug. The storage temperature and conditions are also mentioned, along with the information about the container and the manufacturer.*

PRINCIPAL DISPLAY PANEL – Bendamustine HCl for Injection, USP 100 mg Vial Label - ben0e 0004 05

PRINCIPAL DISPLAY PANEL – Bendamustine HCl for Injection, USP 100 mg Vial Label - ben0e 0004 05

PRINCIPAL DISPLAY PANEL – Bendamustine HCl for Injection, USP 100 mg Carton - ben0e 0004 06

PRINCIPAL DISPLAY PANEL – Bendamustine HCl for Injection, USP 100 mg Carton - ben0e 0004 06

This is a description of a medication known as Bendamustine HCI for injection. Each vial contains 100mg of Bendamustine HCI, USP and 170mg of mannitol, USP. The drug is a cytotoxic agent for intravenous infusion only. The drug requires reconstitution with 20 mL of sterile water for injection before use and the final solution must be used within 24 hours when stored refrigerated or within 3 hours when stored at room temperature. The medication should be handled with caution and safety gloves and glasses should be used to avoid exposure. The Meitheal Pharmaceuticals manufactured the drug, and the product should be retained in the carton until the time of use and discard unused portions.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.